...
首页> 外文期刊>Journal of gastroenterology and hepatology >Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.
【24h】

Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.

机译:印度的幽门螺杆菌疗法:与空泡细胞毒素(vacA)基因的特定等位基因相关的根除效率差异。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND AND AIMS: The efficiency of Helicobacter pylori eradication varies geographically, as do many parameters that might affect therapeutic efficiency, including bacterial genotype. The aim of the present study was to determine the efficiency of H. pylori eradication using a 10-day proton pump inhibitor-based triple-therapy regimen (omeprazole, clarithromycin and amoxycillin) in an eastern Indian patient population, and to find out the relationship, if any, of the success or failure of the therapy to known features of bacterial genotype. METHODS: Helicobacter pylori infections were analyzed in 66 duodenal ulcer patients by upper gastrointestinal endoscopy, rapid urease tests, histology and culture. The cytotoxin-associated gene (cagA) and vacuolating cytotoxin (vacA) gene status of cultured strains were studied by polymerase chain reaction. Treatment was given for 10 days and endoscopy was repeated at 4 and 12 weeks post therapy to monitor ulcer healing and H. pylori eradication. RESULTS: Ulcer healing was observed in 60 patients (96.77%). Helicobacter pylori was eradicated in 41 (62.12% intention to treat, 66.13% per protocol) of the 66 duodenal ulcer patients, but not in the other 25. The bacteria from 47 patients were genotyped. The only significant disease-associated difference in patterns observed was that the vacA m1 allele was represented more disproportionately among patients with eradication failures (68%) than in those with successful eradication (39%) (P < 0.05) No significant association of vacAs1 (signal sequence allele) or cag pathogenicity island status with persistence was detected. CONCLUSIONS: This study highlights the public health need for cheaper, more cost-effective anti-H. pylori therapies for developing countries, and suggests that subtle features of bacterial genotype can influence therapeutic efficiency. The possibility that particular vacA mid region alleles affect persistence, perhaps through toxin action on particular gastric cell types, merits further study.
机译:背景与目的:根除幽门螺杆菌的效率在地理上会有所不同,许多可能影响治疗效率的参数(包括细菌基因型)也会发生变化。本研究的目的是确定在印度东部患者群体中使用基于10天质子泵抑制剂的三联疗法(奥美拉唑,克拉霉素和阿莫西林)根除幽门螺杆菌的效率,并找出两者之间的关系(如果有)针对细菌基因型已知特征的治疗成功或失败。方法:对66例十二指肠溃疡患者的幽门螺杆菌感染进行了上消化道内镜检查,快速尿素酶检测,组织学和培养分析。通过聚合酶链反应研究了培养菌株的细胞毒素相关基因(cagA)和空泡细胞毒素(vacA)基因状态。给予治疗10天,并在治疗后4周和12周重复内镜检查,以监测溃疡的愈合情况和根除幽门螺杆菌的情况。结果:60例患者溃疡愈合(96.77%)。在66例十二指肠溃疡患者中,有41例已消灭了幽门螺杆菌(62.12%的患者要治疗,66.13%的方案),而其他25例则未消灭。对47例患者的细菌进行了基因分型。观察到的唯一与疾病相关的显着模式差异是,根除失败的患者(68%)中的vacA m1等位基因比根除成功的患者(39%)所占比例更大(P <0.05)。信号序列等位基因)或cag致病岛状态持续存在。结论:本研究强调了公共卫生对更便宜,更具成本效益的抗H的需求。幽门螺杆菌治疗发展中国家,并暗示细菌基因型的细微特征可影响治疗效率。特定vacA中部等位基因可能通过对特定胃细胞类型的毒素作用而影响持久性的可能性值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号